XML 55 R30.htm IDEA: XBRL DOCUMENT v3.25.3
Collaboration and License Agreements (Tables)
 12 Months Ended
Sep. 30, 2025
Collaboration And License Agreements [Abstract]  
Schedule of Revenue
The following table provides a summary of revenue recognized:
Year Ended September 30,
202520242023
(in thousands)
GSK$2,645 $2,685 $29,657 
Horizon— — 23,206 
Takeda— 866 162,516 
Janssen— — 356 
Amgen— — 25,000 
Sarepta696,803 — — 
Sanofi$130,000 $— $— 
Total$829,448 $3,551 $240,735 
Schedule of Receivables and Contract Liabilities
The following table summarizes the balance of receivables and contract liabilities related to the Company’s collaboration and license agreements:
September 30,
20252024
(in thousands)
Receivables included in accounts receivable$6,824 $— 
Contract liabilities included in deferred revenue
$2,399 $—